EMYIF yields 16.13% · MRK yields 2.76%● Live data
📍 EMYIF pulled ahead of the other in Year 1
Combined, EMYIF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of EMYIF + MRK for your $10,000?
Euromoney Institutional Investor PLC, together with its subsidiaries, provides business-to-business information services in the United Kingdom, North America, and internationally. The company operates through three segments: Fast Markets, Financial & Professional Services, and Asset Management. The Fast Market segment provides commodity price benchmarks and analysis to its clients' business processes and workflows in the metals, mining, forest products, and agriculture industries. The Financial & Professional Services segment offers actionable data, market and people intelligence, accreditation, marketing, and event services to financial and professional services businesses. The Asset Management segment provides independent research that enables its customers to make informed investment decisions; runs networks and conferences that bring asset allocators and managers together; and offers news and data for the industry to stay informed and make deals. It also engages in the research and data service, publishing, property holding activities. The company was formerly known as Euromoney Publications PLC and changed its name to Euromoney Institutional Investor PLC in April 1999. The company was incorporated in 1969 and is headquartered in London, the United Kingdom. As of November 24, 2022, Euromoney Institutional Investor PLC was taken private.
Full EMYIF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.